Physician profile
Christopher E Talbot
NPI 1558899468
$10,740.25
in general payments reported to CMS, 2019-2025
13 companies · $5,118 in 2025
The $5,118 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $5,622 · 2025: $5,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,930 · Food and Beverage: $3,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,929.71 |
| Food and Beverage | $3,810.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,138.54 | 2024-2025 | Everest Spinal System, Cascadia Interbody System, Tritanium |
| Medtronic, INC. | $2,544.74 | 2024-2025 | Cd Horizon Spinal System, Unid_pass, Mazor X System |
| Medical Device Business Services, INC. | $1,677.41 | 2024 | Viper |
| Arthrex, INC. | $1,526.45 | 2025 | |
| United Orthopedics LLC | $461.48 | 2024-2025 | |
| Baxter Healthcare | $441.47 | 2024 | Actifuse |
| Cerapedics INC. | $255.75 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $221.50 | 2025 | |
| Globus Medical, INC. | $135.74 | 2025 | Independence |
| Orthofix Medical, INC. | $125.00 | 2025 | Northstar |
| Spinal Surgical Strategies, INC. | $93.99 | 2025 | |
| Depuy Synthes Sales INC. | $93.07 | 2025 | Teligen |
| Ethicon US, LLC | $25.11 | 2025 | Stratafix, Surgiflo Hemostatic Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Talbot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.